BioCentury
ARTICLE | Company News

CepTor, Xechem deal

January 5, 2004 8:00 AM UTC

XKEM acquired drug delivery play Ceptor for $6 million in stock, plus the assumption of $300,000 in Ceptor debt. Ceptor shareholders also are eligible for milestones. Ceptor's lead technology, Myodur,...